GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Other Long-Term Liabilities

PharmaSGP Holding SE (XTER:PSG) Other Long-Term Liabilities : €62.7 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE Other Long-Term Liabilities?

PharmaSGP Holding SE's other long-term liabilities for the quarter that ended in Sep. 2024 was €62.7 Mil.

PharmaSGP Holding SE's quarterly other long-term liabilities declined from Mar. 2024 (€66.7 Mil) to Jun. 2024 (€62.7 Mil) but then increased from Jun. 2024 (€62.7 Mil) to Sep. 2024 (€62.7 Mil).

PharmaSGP Holding SE's annual other long-term liabilities increased from Dec. 2021 (€0.3 Mil) to Dec. 2022 (€74.5 Mil) but then declined from Dec. 2022 (€74.5 Mil) to Dec. 2023 (€66.5 Mil).

PharmaSGP Holding SE Other Long-Term Liabilities Historical Data

The historical data trend for PharmaSGP Holding SE's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE Other Long-Term Liabilities Chart

PharmaSGP Holding SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - - - -

PharmaSGP Holding SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaSGP Holding SE Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

PharmaSGP Holding SE Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaSGP Holding SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Other Long-Term Liabilities
Comparable Companies
XTER:HAEK XTER:B8F XTER:PA8 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
PSG:Germany
Address
Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166
Website
https://www.sgp-pharma.com
PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.
Executives
Dr. Clemens Fischer Supervisory Board
Madlena Hohlefelder Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines